A detailed history of Ariadne Wealth Management, LP transactions in Moderna, Inc. stock. As of the latest transaction made, Ariadne Wealth Management, LP holds 19,971 shares of MRNA stock, worth $1.07 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
19,971
Holding current value
$1.07 Million
% of portfolio
0.21%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 23, 2024

BUY
$101.21 - $166.61 $2.02 Million - $3.33 Million
19,971 New
19,971 $277 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $20.9B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ariadne Wealth Management, LP Portfolio

Follow Ariadne Wealth Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ariadne Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Ariadne Wealth Management, LP with notifications on news.